Riders · Animal Health Commission · Article VI: Natural Resources
Cattle Fever Tick Mitigation Clinical Trials
Rider 10 in the 2026-27 Act, page VI-16 · was rider 9
2028-29 request. Animal Health Commission has asked to delete this rider. What it asked for. A request, not law.
Through the session
- 2024-25 Act In current law rider 10
- Introduced (Senate) Amended rider 9
- Introduced (House) Amended rider 9
- Senate substitute Unchanged rider 9
- House substitute Unchanged rider 9
- House passed Unchanged rider 9
- Conference Unchanged rider 9
- 2026-27 Act Unchanged rider 10
Pick any two steps to compare their wording.
What changed in the text
2024-25 Act → Introduced (House): 10 passages changed.
Removed words are struck through; added words are underlined. Sources: 2024-25 Act · Introduced (House).
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | 10 | First version | — | Page VI-16 |
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | 9 was 10 | Amended | — | Page VI-17 |
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | 9 was 10 | Amended | — | Page VI-17 |
| Senate substituteCommittee Substitute for Senate Bill 1 | 9 | Unchanged | Amended | Page VI-14 |
| House substituteHouse Committee Substitute for Senate Bill 1 | 9 | Unchanged | Amended | Page VI-15 |
| House passedSenate Bill 1 as passed the second house | 9 | Unchanged | Amended | Page VI-15 |
| ConferenceConference Committee Report for Senate Bill 1 | 9 | Unchanged | Amended | Page VI-15 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 10 was 9 | Unchanged | Amended | Page VI-16 |
Full text of each wording
Introduced (Senate), Introduced (House), Senate substitute, House substitute, House passed, Conference, 2026-27 Act
Source, page VI-16Cattle Fever Tick Mitigation Clinical Trials. Amounts appropriated above to the Animal Health Commission in Strategy A.1.2, Diagnostic/Epidemiological Support Services, include $30,000 in fiscal year 2026 from the General Revenue Fund for the purposes of completing cattle fever tick mitigation clinical trials that would evaluate the efficacy of three eprinomectin regimens for cattle fever tick control to determine if less frequent treatments can be used to effectively mitigate fever ticks. Any unexpended balances remaining as of August 31, 2026, are appropriated in the fiscal year beginning September 1, 2026, for the same purposes.
2024-25 Act
Source, page VI-16Cattle Fever Tick Mitigation Clinical Trials.
(a) Amounts appropriated above to the Animal Health Commission (TAHC) in Strategy A.1.2, Diagnostic/Epidemiological Support Services, include $87,000 in fiscal year 2024 and $229,000 in fiscal year 2025 from General Revenue for the purposes of conducting cattle fever tick mitigation clinical trials that would evaluate the efficacy of three eprinomectin regimens for cattle fever tick control to determine if less frequent treatments can be used to effectively mitigate fever ticks. Any unexpended balances remaining as of August 31, 2024, are appropriated in the fiscal year beginning September 1, 2024, for the same purposes.
(b) Out of amounts identified in subsection (a), TAHC would evaluate dosing and withdraw periods in weaned beef heifers in phase one.
(c) Out of amounts identified in subsection (a), TAHC shall transfer up to $40,000 of the funds appropriated by this rider in fiscal year 2025 to a Texas state University through an interagency contract to assist in conducting phase two of the clinical trials that would evaluate repeated dosing and withdraw periods in full herd settings.